BridgeMD
Tests treatment safety and results for PTSD (Childbirth-Related)
Official title Feasibility and Efficacy of GTEP for Birth Trauma
ClinicalTrials.gov ID: NCT07246356
What this study is testing
- What it's testing
- This clinical study aims to evaluate the feasibility and initial efficacy of Group Traumatic Episode Protocol (GTEP) for reducing trauma symptoms (measured by the PCL-5 and City BiTS) for individuals following a traumatic birthing experience. A secondary aim is to evaluate the efficacy of GTEP in improving parental wellbeing (measured through the CORE-10) and parent-infant bonding (measured through the PBQ) following a traumatic birthing experience.
- Time commitment: about 18 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, women only
You may be able to join if
- Aged between 18-65 years.
- Currently under the Black Country Perinatal Mental Health Service
- Experiencing self-reported trauma symptoms related to a birthing experience within the last 18 months (this includes the birth itself, the postnatal...
- Access to technology (e.g., laptop, internet connection) to be able to access the online group.
- Access to a confidential space within their home, and childcare for their baby/any other existing children.
You likely can't join if
- Women/birthing people whose baby is no longer under their care.
- Severe and enduring mental health presentations (i.e., diagnosis of bipolar, psychosis and/or schizophrenia.
- Significant sensory impairment (e.g., needing a British Sign Language interpreter).
See the full eligibility criteria
- Aged between 18-65 years.
- Currently under the Black Country Perinatal Mental Health Service
- Experiencing self-reported trauma symptoms related to a birthing experience within the last 18 months (this includes the birth itself, the postnatal hospital stay, and/or any neonatal admissions).
- Access to technology (e.g., laptop, internet connection) to be able to access the online group.
- Access to a confidential space within their home, and childcare for their baby/any other existing children.
- Proficient levels of English Language to engage with the group.
- Ability to engage in group therapy based on clinical presentation.
- Capacity to consent to engage in the GTEP group and research study.
- Women/birthing people whose baby is no longer under their care.
- Severe and enduring mental health presentations (i.e., diagnosis of bipolar, psychosis and/or schizophrenia.
- Significant sensory impairment (e.g., needing a British Sign Language interpreter).
The study team makes the final eligibility decision.
Where it's taking place
- Wolverhampton, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 18 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wolverhampton, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.